Tretinoin cream versus lotion: compare more than the percentage

A dosage form is part of the product

A prescription can share an active ingredient with another product while using a different base. Cream and lotion describe formulations, not a universal ranking from gentle to harsh or weak to strong. Start with the complete product name and the reason a clinician is considering it.

This publication now includes Altreno lotion as an explicit alternative format, alongside standard creams and personalized combinations. Its inclusion does not mean every cream user should switch. It gives readers a way to ask whether a problem with a previous preparation warrants discussing the vehicle, the active strength, the routine or something else.^[source]

Matching percentages do not finish the comparison

Two tretinoin preparations at the same concentration still need to be compared as finished products. Their inactive ingredients, instructions, approved labeling or compounded status, quantity and dispensing arrangement may differ. Conversely, different concentrations should not be compared without considering why each was prescribed.

Nurx lists several cream strengths; Altreno is identified as one 0.05% lotion. Neither fact answers which a particular person needs. AAD guidance emphasizes that retinoid choices depend on the skin concern and tolerance. An online comparison is useful preparation for that decision, not a method of selecting a prescription dose.^{[source][source][source]}

Read the full list when there is a reaction history

A person who reacted to a prior product should bring the actual tube or ingredient information to the assessment. The active may be relevant, but so may supporting ingredients, overlapping products or use conditions. A short panel naming only the active cannot resolve the cause.

Altreno’s manufacturer highlights a fish-protein precaution. That is a concrete example of why the base matters beyond texture preferences. It does not mean every lotion contains fish proteins or that every cream avoids allergens. Keep product-specific warnings attached to that product.^[source]

Do not compare unlike study claims

An acne trial, an aging-skin study and a customer satisfaction survey measure different things. The Altreno label reports vehicle-controlled acne trials. That supports a discussion of the specified product and indication, not a general claim that lotions are better than creams or that the lotion is approved to treat wrinkles.^[source]

Compounded combinations need their own evidence boundary. FDA does not approve compounded finished medicines. Ingredient research may inform a clinician’s rationale, but it should not be treated as proof that every custom mixture performs identically to a studied product.^[source]

Make the comparison usable at the consultation

Record five details for each proposed option: the active and strength, complete formula or manufacturer, intended treatment goal, quantity and cost, and plan for follow-up. Add the name and timing of any previous reaction. That is a more useful conversation starter than asking which texture is “best.”

Use the standard cream review and lotion review to identify missing information. If the issue is an uncomfortable existing prescription, seek advice about that treatment rather than changing format or concentration on the basis of a product comparison alone.

Keep reading